“IDENTIFICATION OF ENDOGENOUS SUPEROXIDE DISMUTASE AS A POTENTIAL INHIBITOR FOR PI3K AKT SIGNALING IN COLORECTAL CANCER - A MOLECULAR DOCKING STUDY”. Journal of Pharmaceutical Negative Results, Oct. 2022, pp. 1374-9, https://doi.org/10.47750/pnr.2022.13.S03.214.